<DOC>
	<DOCNO>NCT01370954</DOCNO>
	<brief_summary>This study observational study patient prescribe CerefolinNAC® invited participate survey regard experience CerefolinNAC® . CerefolinNAC® medical food indicate distinct nutritional requirement individual treatment early memory loss particular emphasis individual diagnose risk neurovascular oxidative stress and/or hyperhomocysteinemia ; mild moderate cognitive impairment without vitamin B12 deficiency , vascular dementia Alzheimer 's disease . The purpose study increase understand role CerefolinNAC® manage proper neuronal function brain , provide patient personalized education support , contribute overall understanding need concern patient treat early memory loss .</brief_summary>
	<brief_title>NAC-003 P.L.U.S . Program ( Progress Through Learning Understanding &amp; Support )</brief_title>
	<detailed_description>Surveys use conduct study administer via telephone InfoMedics , Inc. , company establish system develop patient-physician feedback program . Participating physician ask patient participate program CerefolinNAC® prescribe provide brochure contain introduction program instruction enroll . Patients self-enroll , take brief survey start CerefolinNAC® prescription , two brief follow-up survey 6 week 12 week . As patient complete survey within study , physician receive individualize feedback report outline patient 's treatment experience progress . Patients also receive copy report , help encourage continue take CerefolinNAC® direct . Patients also receive educational material manage early memory loss .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Dementia , Vascular</mesh_term>
	<mesh_term>Memory Disorders</mesh_term>
	<mesh_term>Amnesia</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<criteria>New CerefolinNAC® Start Only patient prescribe CerefolinNAC® help metabolic management early memory loss . If participant indicate get prescription CerefolinNAC® , he/she able complete survey ( ) . For followup survey , participant indicate he/she take CerefolinNAC® , he/she able complete survey ( ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>CerefolinNAC</keyword>
	<keyword>early memory loss</keyword>
	<keyword>pre-alzheimer 's disease</keyword>
	<keyword>cognitive function</keyword>
	<keyword>folic acid</keyword>
	<keyword>folate</keyword>
	<keyword>L-methylfolate</keyword>
	<keyword>vitamin B12</keyword>
	<keyword>methylcobalamin</keyword>
	<keyword>N-acetylcysteine</keyword>
	<keyword>NAC</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>memory deficit</keyword>
	<keyword>antioxidant</keyword>
</DOC>